Related Experiment Video
Updated: Sep 11, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Hematopoietic Stem Cell Donors' Experiences of Information and Side-Effects During the First Year After Donation-A
Annika M Kisch1,2, Jeanette Winterling3,4, Hans Hägglund5
1Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
Insights
Hematopoietic stem cell (HSC) donors generally report positive experiences, with most side effects resolving quickly. Enhanced information on potential severe side effects may improve donor satisfaction.
Area of Science:
- Hematology
- Transplantation Medicine
- Donor Health
Background:
- Understanding hematopoietic stem cell (HSC) donor experiences is crucial for recruitment and retention.
- Focus on donor information and side effects during the first year post-donation is essential.
Purpose of the Study:
- To describe the experiences of HSC donors, specifically regarding information received and side effects encountered.
- To evaluate donor satisfaction in relation to information and adverse events within the first year after donation.
Main Methods:
- Prospective Swedish cohort study of adult HSC donors (2019-2022).
- Utilized questionnaires at four time points: pre-donation to 12 months post-donation.
- Included 173 unrelated and 68 related donors, with most donating peripheral blood stem cells.
Main Results:
- Over 83% of donors reported at least one side effect, typically resolving within 2 weeks.
- All but one donor rated their experience as good or very good.
- Lower satisfaction with information and donation was noted among donors experiencing severe side effects or those donating via bone marrow or unrelated donation.
Conclusions:
- Current donor follow-up protocols appear adequate, with a need for individualized follow-up for persistent symptoms.
- Enhanced pre-donation information regarding the risk of severe or prolonged side effects is recommended.
- Further evaluation of enhanced information's impact on donor satisfaction is warranted.
Abstract:
The aim was to describe hematopoietic stem cell (HSC) donors' experiences focusing on information and side effects during the first year after donation. Our prospective Swedish cohort study with adult HSC donors was performed from 2019 to 2022, with questionnaires at four time points from before until 12 months after donation. 173 unrelated and 68 related donors participated, and the majority donated peripheral blood stem cells. All but one rated their donation experience as good or very good. At least one side effect was reported by 83% of participants. Six donors (2.5%) experienced either numerous side effects, at least one severe side effect, or prolonged side effects. Satisfaction with information was lower among donors having severe side effects and bone marrow donors. Overall satisfaction with the donation was lower among donors having severe side effects and unrelated donors. Donors were generally satisfied with the pre-donation information. Most experienced side effects that resolved within 2 weeks, which strengthens the case for unchanged donor follow-up 1 month after donation, with individualized follow-up for donors with persistent symptoms. Enhanced information regarding the risk of more severe or prolonged side effects appears warranted, and its effect on donor satisfaction should be evaluated.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Regulation of Hematopoietic Stem Cells
Kidney Transplant I: Introduction
Hematopoiesis
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Multipotency of Hematopoietic Stem Cells

